Ligand validation:4CQ9

ORO: OROTIC ACID

ORO is a Ligand Of Interest in 4CQ9 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4CQ9_ORO_A_900	86%	5%	0.11	0.978	1.8	3.62	3	3	1	0	100%	1
4CQ9_ORO_B_900	81%	5%	0.126	0.978	1.81	3.47	3	3	1	0	100%	1
7KZ4_ORO_B_1003	99%	11%	0.051	0.981	1.11	2.98	-	4	0	0	100%	1
6GJG_ORO_A_602	93%	4%	0.09	0.986	2.12	3.48	4	4	0	0	100%	1
5DEL_ORO_A_602	89%	14%	0.085	0.964	1.23	2.56	-	3	0	0	100%	1
7KZY_ORO_A_1003	87%	22%	0.079	0.952	1.39	1.84	-	2	0	0	100%	1
7KYY_ORO_B_1003	87%	18%	0.107	0.98	1.29	2.22	-	2	0	0	100%	1
9DHH_ORO_A_402	100%	8%	0.025	0.992	1.58	3.05	2	2	0	0	100%	1
6FMD_ORO_A_411	100%	9%	0.034	0.992	1.02	3.42	1	2	0	0	100%	1
9DHI_ORO_A_402	100%	0%	0.032	0.99	2.36	6.63	2	4	0	0	100%	1
9DHJ_ORO_A_402	100%	1%	0.033	0.989	2.35	6.35	2	4	0	0	100%	1
5H73_ORO_A_403	100%	5%	0.035	0.989	2.56	2.79	5	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.